Health News: [cancer]

Sponsored Link Special Offer - Free Trial of Blockbuster.com Rent Movies from Blockbuster.com. Delivered Direct To Your Mailbox. Click here to start today. ---------------------------------------------------------------------------------------------------------- Wednesday, October 10, 2012 10:57 AM PDT Your Health News Alert for [cancer] matched the following stories: Reuters via Yahoo! Canada News, Wed, 10 Oct 2012 06:30 AM PDT Cell receptor research wins Americans chemistry Nobel http://ca.news.yahoo.com/cell-receptor-wins-nobel-prize-chemistry-095649389.html STOCKHOLM (Reuters) - Two American scientists won the 2012 Nobel Prize for chemistry on Wednesday for research into how cells respond to external stimuli that is helping to develop better drugs to fight diseases such as diabetes, cancer and depression. The Royal Swedish Academy of Sciences said the 8 million crown ($1.2 million) prize went to Robert Lefkowitz, 69, and Brian Kobilka, 57, for ... The Florida Times-Union, Wed, 10 Oct 2012 04:06 AM PDT African-American men report chronic problems in Shands Jacksonville health study http://jacksonville.com/news/health-and-fitness/2012-10-10/story/african-american-men-report-chronic-problems-shands About 27 percent of the African-American men surveyed for the University of Florida Shands Cancer Center's Black Men's Health Community Report reported high blood pressure, while almost 11 percent said they had diabetes and 11 percent said they had arthritis. Reuters via Yahoo! Canada News, Wed, 10 Oct 2012 00:38 AM PDT Oxford Bio abandons prostate cancer vaccine study http://ca.news.yahoo.com/oxford-bio-abandons-prostate-cancer-vaccine-study-073857356--finance.html LONDON (Reuters) - Britain's Oxford BioMedica said on Wednesday it was closing a mid-stage clinical trial of its cancer vaccine TroVax in U.S. patients with prostate cancer, dealing a further blow to the troubled product. Shares in the company fell more than 9 percent on the news. The group had been testing TroVax in men with progressive hormone refractory prostate cancer but it faced an uphill ... ANI via Yahoo! India News, Tue, 09 Oct 2012 21:58 PM PDT Regular aspirin use can slash risk of serious ovarian cancer http://in.news.yahoo.com/regular-aspirin-slash-risk-serious-ovarian-cancer-045807825.html Washington, October 10 (ANI): Women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serious ovarian cancer-an aggressive carcinoma affecting the surface of the ovary, a study has found. AFP via Yahoo! UK & Ireland News, Tue, 09 Oct 2012 17:22 PM PDT Menopause drugs: Study stokes new debate over cancer risk http://uk.news.yahoo.com/menopause-drugs-study-stokes-debate-over-cancer-risk-215910408.html Women who start hormone replacement therapy (HRT) soon after menopause do not show higher cancer incidence within 16 years, according to a Danish study published that fuels scientific discord over the treatment's safety. The Florida Times-Union, Tue, 09 Oct 2012 13:01 PM PDT Breast Cancer calendar http://jacksonville.com/news/health-and-fitness/2012-10-09/story/breast-cancer-calendar Events in honor of Breast Cancer Awareness Month for October. See more health stories that match your keyword at: http://search.news.yahoo.com/search/news/?fr=yalerts-health&c=&p=cancer+%2bcat%3ahealth&ei=utf-8 Visit Yahoo! Health: http://health.yahoo.com/ You received this email because you subscribed to Yahoo! Alerts. Use http://us.rd.yahoo.com/alerts/b/email/unsubscribe/*http://alerts.yahoo.com/unsubscribe.php?id=8KnvIEkuNLOQsNjZKOdTAKC7sHaMGrYP6676rLS1KZTPXbmyxEZEHlt6jwW9nq8A1huLSR1OBnIKmd2rRBVtuoDpBS3ZAoz0m97I to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences: http://login.yahoo.com/config/login_verify2?.done=http://subscribe.yahoo.com/showaccount . To learn more about Yahoo!'s use of personal information, please read our privacy policy at http://privacy.yahoo.com/privacy/us/ . Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.